NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael BenkowitzPRESIDENT AND COO2026-02-097,875$146.03
$1.15MBuy
Michael BenkowitzPRESIDENT AND COO2026-02-0914,625$474.65
$6.94MSell
Michael BenkowitzPRESIDENT AND COO2026-02-0914,625$117.76
$1.72MBuy
Michael BenkowitzPRESIDENT AND COO2026-02-097,875$474.65
$3.74MSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-05477$480.92
$229.40kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-058,300$146.03
$1.21MBuy
Paul A. MahonEVP GENERAL COUNSEL2026-02-05675$485.52
$327.72kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-05934$484.92
$452.91kSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-052,748$483.92
$1.33MSell
Paul A. MahonEVP GENERAL COUNSEL2026-02-051,103$482.57
$532.27kSell

1 of 95

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.43%5,352,996$2.53BInstitution
Lilly Co Eli12.20%5,251,394$2.48BInsider
Vanguard Group Inc10.26%4,418,610$2.09BInstitution
Renaissance Technologies LLC5.05%2,173,392$1.03BInstitution
Avoro Capital Advisors LLC4.70%2,022,222$956.75MInstitution
State Street Corp4.47%1,922,609$909.62MInstitution
Wellington Management Group LLP3.25%1,398,781$661.79MInstitution
Geode Capital Management LLC2.90%1,249,660$591.24MInstitution
Aqr Capital Management LLC2.29%986,478$466.72MInstitution
Martine A. Rothblatt1.95%838,072$396.51MInsider

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR86.71%13.29%Net SellingNet Selling
INCY77.71%22.29%Net SellingNet Selling
GMAB96.17%0.00%
ROIV42.61%57.39%Net SellingNet Selling
RVMD90.89%9.11%Net SellingNet Selling

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 94.94% institutional shareholders, 14.55% United Therapeutics insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 12.20% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.48B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.